Journey Medical (DERM) Price to FCF (2021 - 2026)

Journey Medical (DERM) has reported Price to FCF for 6 consecutive years, with 112.26 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to FCF rose 36.76% year-over-year to 112.26; the trailing twelve-month figure through Jun 2026 stood at 25.98 (up 57.96% YoY), and the FY2025 full-year result was 13.1, down 295.76% from the prior year.
• Price to FCF eased to 112.26 in Q2 2026 per DERM's latest filing, from 44.02 in the prior quarter.
• Across five years, Price to FCF topped out at 44.02 in Q1 2026 and bottomed at 177.52 in Q2 2025.
• Historically, Price to FCF has averaged 28.91 across 5 years, with a median of 11.63 in 2024.
• The widest YoY moves for Price to FCF: up 664.79% in 2024, down 3826.03% in 2024.
• Over 5 years, Price to FCF stood at 8.77 in 2022, then grew by 27.55% to 6.36 in 2023, then surged by 664.79% to 35.9 in 2024, then slumped by 172.26% to 25.94 in 2025, then sank by 332.71% to 112.26 in 2026.
• According to Business Quant data, Price to FCF over the past three periods registered 112.26, 44.02, and 25.94 for Q2 2026, Q1 2026, and Q4 2025 respectively.